SEC Form 4 · accession 0000874015-17-000028
IONIS PHARMACEUTICALS INC · IONS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Stanley T Crooke
Officer — Chairman and CEO · Director
Period of report
Apr 19, 2017
Accepted (ET)
Apr 21, 2017 · 5:42 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000874015
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Apr 19, 2017 | M | 5,000 | $7.25 | A | 43,014 | D | |
| Common StockF1 | Apr 19, 2017 | S | 5,000 | $43.25 | D | 38,014 | D | |
| Common StockF2 | Apr 19, 2017 | M | 500 | $7.25 | A | 3,562 | I | By wife |
| Common StockF2 | Apr 19, 2017 | S | 500 | $43.25 | D | 3,062 | I | By wife |
| Common Stock | holding | — | — | — | 725,391 | I | By trust |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (right to buy) | $7.25 | Apr 19, 2017 | M | 5,000 | D | Jan 3, 2016 | Jan 2, 2019 | Common Stock | 5,000 | 28,462 | D |
| Employee Stock Option (right to buy) | $7.25 | Apr 19, 2017 | M | 500 | D | Jan 3, 2016 | Jan 2, 2019 | Common Stock | 500 | 10,404 | I |
Explanation of responses
- F1Acquired as a result of exercising a stock option pursuant to Rule 10b5-1 Trading Plan. The purchase and sale reported on this Form 4 was effective pursuant to Rule 10b5-1 Trading Plan adopted by the reporting person on 9/21/2015.
- F2Acquired as a result of exercising a stock option pursuant to Rule 10b5-1 Trading Plan. The purchase and sale reported on this Form 4 was effective pursuant to Rule 10b5-1 Trading Plan adopted by the reporting person's wife on 9/21/2015.